Page 43 - Noble-Virtual-Healthcare-2024

Ocugen, Inc.

SELECTED FINANCIAL ITEMS OCGN

(in millions of USD)
CQ1 '23 CQ2 '23 CQ3 '23 CQ4 '23 LTM
Income Statement Key Items
Total Revenue NA NA NA NA 0.00
Gross Profit (17.21) (9.56) (14.17) (6.34) (47.28)
Gross Margin NM NM NM NM NM
EBIT (24.15) (17.75) (23.73) (15.42) (81.06)
EBIT Margin NM NM NM NM NM
Net Income to Common Shareholders (21.94) (16.50) (22.93) (14.16) (75.52)
Net Margin NM NM NM NM NM

Balance Sheet Key Items
Total Assets 108.63 96.30 88.98 74.69 74.69
Cash & Short Term Investments 77.56 68.26 70.58 53.48 53.48
% of Assets 71% 71% 79% 72% 72%
Current Assets -Total 98.49 84.40 73.45 56.56 56.56
% of Assets 91% 88% 83% 76% 76%
Total Liabilities 24.58 20.50 18.70 16.29 16.29
% of Assets 23% 21% 21% 22% 22%
Current Liabilities - Total 18.46 15.68 13.46 11.14 11.14
% of Assets 17% 16% 15% 15% 15%
Long Term Debt 2.29 1.06 1.47 1.50 1.50
% of Assets 2% 1% 2% 2% 2%
Total Equity 84.05 75.80 70.28 58.40 58.40
% of Assets 77% 79% 79% 78% 78%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (16.91) (18.24) (18.81) (13.71) (67.67)
Net Cash Flow - Investing (15.30) 3.44 5.72 (3.37) (9.50)
Net Cash Flow - Financing 8.18 5.50 15.40 (0.04) 29.04

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Nineteenth Annual Small & Microcap Investor Conference